Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant lymphoma, mixed cell type, diffuse.

B N Nathwani, G E Metter, R A Gams

    Blood
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

    Nature communications·2014
    Same author

    Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins.

    British journal of cancer·2013
    Same author

    Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification.

    Leukemia & lymphoma·2002
    Same author

    Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002
    Same author

    Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.

    Arthritis and rheumatism·2002
    Same author

    An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH).

    The journals of gerontology. Series A, Biological sciences and medical sciences·2001
    Same journal

    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

    Blood·2026
    Same journal

    Identifying steroid-refractory aGVHD before it happens.

    Blood·2026
    Same journal

    ELISA-negative HIT: antibody recognition and relevance.

    Blood·2026
    Same journal

    EBV and immunodeficiency: the odd couple drawn to the brain.

    Blood·2026
    Same journal

    A bone to pick with ferric carboxymaltose.

    Blood·2026
    Same journal

    A step toward streamlining HIT diagnosis.

    Blood·2026
    See all related articles

    Diffuse mixed cell lymphoma subtypes show distinct prognoses. Follicular center cell origin (FCC) subtypes have better survival, while non-FCC types are aggressive, particularly when complete remission is not achieved.

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Diffuse mixed cell lymphoma (DMCL) encompasses heterogeneous subtypes with varying clinical outcomes.
    • Morphological classification is crucial for understanding DMCL behavior and patient prognosis.

    Purpose of the Study:

    • To investigate clinical differences between morphological subtypes of diffuse mixed cell lymphoma.
    • To compare survival outcomes based on follicular center cell origin (FCC) versus non-FCC subtypes.

    Main Methods:

    • Retrospective analysis of 62 diffuse mixed cell lymphoma patients from a collaborative study.
    • Histopathological review to classify subtypes as FCC, non-FCC, unresolved, or unclassifiable.
    • Survival analysis using Cox regression to compare outcomes between FCC and non-FCC groups.

    Related Experiment Videos

    Main Results:

    • Patients with FCC subtype (16/62) demonstrated a trend towards longer survival compared to non-FCC subtype (34/62) (p=0.07).
    • In the non-FCC group, complete remission (CR) significantly improved survival (p=0.003), with a median survival of 20 months.
    • In the FCC group, CR did not significantly impact survival (p=0.32), and all CR patients were alive.

    Conclusions:

    • Non-FCC diffuse mixed cell lymphoma is characterized as a high-grade malignant lymphoma.
    • FCC-type diffuse mixed cell lymphoma exhibits a more indolent behavior.
    • Morphological subtyping is essential for predicting diffuse mixed cell lymphoma prognosis and guiding treatment strategies.